FDA-cleared system for percutaneous surgery offers the strength and
functionality of a traditional 5 mm minimally invasive tool but requires
fewer trocars and potentially causes less trauma
Percutaneous insertions mean no trocars are required for initial
access
Compared to traditional laparoscopic surgery, percutaneous surgery
can be even less invasive
Patients expected to heal with minimal scarring
WAYNE, Pa.--(BUSINESS WIRE)--Mar. 16, 2015--
Teleflex Incorporated (NYSE: TFX), a leading global provider of medical
devices for critical care and surgery, has announced today that its new
Percuvance™ Percutaneous Surgical System, which provides performance
similar to larger tools commonly used in minimally invasive laparoscopic
surgeries, was percutaneously inserted into a human for the first time
in a procedure at Cleveland Clinic to evaluate the surgical tool.
The Percuvance System has recently received FDA clearance and CE Mark
approval and represents a significant advance in minimally invasive
surgery (MIS). The basis of the system is a less than 3 mm diameter
shaft that, when connected to an introducer tool tip, can be inserted
percutaneously through the skin. The introducer tool tip can then be
exchanged outside the body for a wide variety of 5 mm interchangeable
surgical tool tips. The shaft is sufficiently strong to hold structures,
and surgeons can use its interchangeable tool tips to grasp, cut and
manipulate tissue.
In addition, procedures using the Percuvance™ System require fewer
trocars and cause less trauma for the patient.
“The first human procedures with the Percuvance™ System are a major
milestone in our strategy of developing platform technologies that will
broaden Teleflex’s portfolio with novel products that provide clinical
efficacy, enhance patients’ experiences and lower the overall cost of
care,” says John Tushar, President and General Manager of Teleflex
Surgical. “We believe our system has the potential to transform the
standard of care from traditional laparoscopy to percutaneous surgery.”
Percutaneous Surgery: A simple stepping stone to even less
invasive minimally invasive surgery (MIS)
The Company’s optimism is grounded in two facts:
1. Traditional laparoscopic surgery accounts for approximately 94
percent of all nonrobotic laparoscopic surgical procedures, and 2.9
million laparoscopic procedures are performed each year in the US.1
2. The transition to even less invasive MIS has been slowed by barriers
to adoption. Percutaneous surgery eliminates these barriers.
According to surgeons interviewed during the product's development, the
Percuvance™ System has a short learning curve. It requires few
adjustments to surgeons’ current techniques as well as much smaller
incisions. Plus, the system does not have the costs associated with
capital, service and fully disposable technologies.
About the Percuvance™ System
Teleflex’s Percuvance™ Percutaneous Surgical System is intended to
manipulate tissue. It includes components that introduce a variety of
instrument configurations into the abdominal cavity and requires a
smaller incision site than traditional laparoscopic surgery. It offers a
reusable handle that is compatible with interchangeable instrument tips,
which include graspers, scissors and dissectors. Unlike other
laparoscopic devices, the Percuvance™ System affords a percutaneous
insertion into the patient without the use of a trocar. It is indicated
for the means to penetrate soft tissue to access certain areas of the
abdomen and used to grasp, hold and manipulate tissue during
laparoscopic surgery. The Percuvance™ System will become widely
commercially available in 2016.
Click
here for more information
Teleflex Portfolio of Percutaneous Solutions
The Percuvance™ System complements another key product, MiniLap®
Percutaneous Surgical System, in Teleflex’s growing portfolio of
innovative yet practical solutions for percutaneous surgery. The
MiniLap® System provides delivery and function through an integrated,
disposable 2.3 mm device. Like the Percuvance™ System, the MiniLap®
System does not require a trocar and makes minimally invasive
laparoscopic procedures less invasive.
Initially, both the Percuvance™ and MiniLap® Systems will play
supporting roles in common, less complex procedures in general surgery
(e.g., lap cholecystectomies or appendectomies) and gynecological
surgery. As they gain experience, surgeons also may find these devices
valuable in more complex abdominal procedures. Teleflex expects to add
more tools to the next generation Percuvance™ System and envisions it
having an increasingly important role in a wide range of common and
complex procedures.
“Teleflex Percutaneous Solutions comprise an innovative and unparalleled
portfolio of devices to perform percutaneous surgery,” commented Benson
Smith, Chairman, President and Chief Executive Officer of Teleflex. “We
believe they fill an important clinical and economic need in the
surgical field and expect they will contribute to our growth.”
About Teleflex Incorporated
Teleflex is a leading global provider of specialty medical devices for a
range of procedures in critical care and surgery. Our mission is to
provide solutions that enable healthcare providers to improve outcomes
and enhance patient and provider safety. Headquartered in Wayne, PA,
Teleflex employs approximately 11,700 people and serves healthcare
providers worldwide.
Additional information about Teleflex can be obtained from the company's
website at teleflex.com.
Forward-Looking Statements
Any statements contained in this press release that do not describe
historical facts may constitute forward-looking statements. Any
forward-looking statements contained herein are based on our
management's current beliefs and expectations, but are subject to a
number of risks, uncertainties and changes in circumstances, which may
cause actual results or company actions to differ materially from what
is expressed or implied by these statements. These risks and
uncertainties are identified and described in more detail in our filings
with the Securities and Exchange Commission, including our Annual Report
on Form 10-K.
Teleflex®, Percuvance™ and MiniLap® are trademarks or registered
trademarks of Teleflex Incorporated or its affiliates. © 2015 Teleflex
Incorporated. All rights reserved. MC-001051
1 Source: Millennium Research Group, Inc, RPUS30LA13
Source: Teleflex Incorporated
Teleflex Contact:
Teleflex Incorporated
Jake Elguicze,
610-948-2836
Jake.elguicze@teleflex.com
or
Media
Contact:
Sam Brown Inc.
Mariesa Kemble, 608-850-4745
mariesakemble@sambrown.com